Biomarkers help tailor diuretic use in acute heart failure patients

Athens, Greece – 25 May 2019: Adrenomedullin activity predicts which acute heart failure patients are at the greatest risk of death without diuretic treatment post-discharge, according to late breaking research presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC).1 “Therapy at discharge often remains unchanged for several weeks…